Focusing on increased glutamine uptake by ASCT2 in tumour cells, glutamine has been utilized as an imaging agent like 18F-fluorodeoxyglucose, which has been clinically used as a powerful diagnosis tool to visualize the malignant tissues possessing the augmented glucose uptake. The gene discussed is SLC1A5; the disease is neoplasm.